Related Experiment Video
Updated: Jun 10, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor
Shizhong Li1, Elisabeth Bock, Vladimir Berezin
1Protein Laboratory, Department of Neuroscience and Pharmacology, Panum Institute, University of Copenhagen, Copenhagen N, Denmark; E-Mails: li@sund.ku.dk (S.L.); bock@sund.ku.dk (E.B.).
Abstract:
Fibroblast growth factor receptors (FGFRs) interact with their cognate ligands, FGFs, and with a number of cell adhesion molecules (CAMs), such as the neural cell adhesion molecule (NCAM), mediating a wide range of events during the development and maintenance of the nervous system. Determination of protein structure, in silico modeling and biological studies have recently resulted in the identification of FGFR binding peptides derived from various FGFs and NCAM mimicking the effects of these molecules with regard to their neuritogenic and neuroprotective properties. This review focuses on recently developed functional peptide agonists of FGFR with possible therapeutic potential.
Insights
Researchers identified novel peptide agonists that activate Fibroblast Growth Factor Receptors (FGFRs). These peptides mimic FGFs and NCAM, showing promise for neuroprotection and neuritogenesis in the nervous system.
Area of Science:
- Neuroscience
- Molecular Biology
- Drug Discovery
Background:
- Fibroblast Growth Factor Receptors (FGFRs) are crucial for nervous system development and maintenance.
- FGFRs interact with ligands (FGFs) and cell adhesion molecules (CAMs) like NCAM.
- These interactions mediate critical cellular events in the nervous system.
Purpose of the Study:
- To review recently developed functional peptide agonists of FGFR.
- To explore the therapeutic potential of these novel peptides.
- To highlight peptides mimicking FGFs and NCAM for FGFR activation.
Main Methods:
- Protein structure determination.
- In silico modeling.
- Biological studies to identify and characterize peptide agonists.
Main Results:
- Identification of FGFR binding peptides derived from FGFs and NCAM.
- Demonstration that these peptides mimic the neuritogenic and neuroprotective effects of native molecules.
- Characterization of functional peptide agonists for FGFR.
Conclusions:
- Novel peptide agonists targeting FGFRs have been developed.
- These peptides exhibit therapeutic potential for nervous system disorders.
- Further research into FGFR-targeting peptides could lead to new treatments.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle

